Kamat - Figure 23

Journal of Clinical Oncology

References

[21]

Kamat AM, Sylvester RJ, Böhle A, et al. Definitions, end points, and clinical trial designs for non-muscle-invasive bladder cancer: recommendations from the International Bladder Cancer Group. J Clin Oncol. 2016;34:1935−44  https://doi.org/10.1200/JCO.2015.64.4070

[22]

Lerner SP, Dinney C, Kamat AM, et al. Clarification of bladder cancer disease states following treatment of patients with intravesical BCG. Bladder Cancer. 2015;1:29−30  https://dx.doi.org/10.3233%2FBLC-159002